View on Pubmed.gov 32586280 | View on doi.org 10.1186/s12885-...
MiR-34c downregulation leads to SOX4 overexpression and cisplatin resistance in nasopharyngeal carcinoma.
- Princess Margaret Cancer Centre, University Health Network, Toronto, Canada.
- Department of Medical Biophysics, University of Toronto, Toronto, Canada.
- LabEx DEVweCAN, Université de Lyon, F-69000, Lyon, France.
- School of Biomedical Sciences, Li Ka Shing Faculty of Medicine, University of Hong Kong, Hong Kong, China.
- Princess Margaret Cancer Centre, University Health Network, Toronto, Canada. Fei-Fei.Liu@rmp.uhn.on.ca.
- Department of Medical Biophysics, University of Toronto, Toronto, Canada. Fei-Fei.Liu@rmp.uhn.on.ca.
- Radiation Medicine Program, Princess Margaret Cancer Centre, University Health Network, 610 University Avenue, Toronto, Ontario, M5G 2M9, Canada. Fei-Fei.Liu@rmp.uhn.on.ca.
- Department of Radiation Oncology, University of Toronto, Toronto, Canada. Fei-Fei.Liu@rmp.uhn.on.ca.
Abstract
BACKGROUND
A major cause of disease-related death in nasopharyngeal carcinoma (NPC) is the development of distant metastasis (DM) despite combination chemoradiotherapy treatment. We previously identified and validated a four microRNA (miRNA) signature that is prognostic for DM. In this study, characterization of a key component of this signature, miR-34c, revealed its role in chemotherapy resistance.
METHODS
Two hundred forty-six NPC patient biopsy samples were subject to comprehensive miRNA profiling and immunohistochemistry (IHC). Two human normal nasopharyngeal cell lines (immortalized; NP69 and NP460), as well as the NPC cell line C666-1, were used for miR-34c gain-of-function and loss-of-function experiments. Signaling pathways were assessed using quantitative real-time PCR (qRT-PCR) and Western blot. Cell viability was measured using the ATPlite assay.
RESULTS
MiR-34c was downregulated in NPC patient samples, and confirmed in vitro to directly target SOX4, a master regulator of epithelial-to-mesenchymal transition (EMT). MiR-34c downregulation triggered EMT-representative changes in NP69 and NP460 whereby Snail, ZEB1, CDH2, and SOX2 were upregulated, while Claudin-1 and CDH1 were downregulated. Phenotypically, inhibition of miR-34c led to cisplatin resistance, whereas miR-34c over-expression sensitized NPC cells to cisplatin. TGFβ1 decreased miR-34c and increased SOX4 expression in vitro. The TGFβ receptor 1 inhibitor SB431542 reduced SOX4 expression and increased cisplatin sensitivity. Finally, IHC revealed that lower SOX4 expression was associated with improved overall survival in chemotherapy-treated NPC patients.
CONCLUSION
miR-34c is downregulated in NPC. Repression of miR-34c was shown to increase SOX4 expression, which leads to cisplatin resistance, while TGFβ1 was found to repress miR-34c expression. Taken together, our study demonstrates that inhibition of the TGFβ1 pathway could be a strategy to restore cisplatin sensitivity in NPC.
References
Oncotarget. 2015 Feb 28;6(6):4537-50
Cancer Res. 2017 Jun 15;77(12):3244-3254
Pigment Cell Melanoma Res. 2016 Jul;29(4):453-8
Prostate Cancer Prostatic Dis. 2013 Dec;16(4):301-7
Cited by 27 citations (total)
Journal Article Review
MiRNA signatures in nasopharyngeal carcinoma: molecular mechanisms and therapeutic perspectives.
Electronic publication date January 8, 2024
Yan Chen [...] Yingchun He et al.
Nasopharyngeal carcinoma (NPC) is a prevalent cancerous tumor that affects the head and neck region. Recent studies have provided compelling...
Journal Article Review
Overcoming therapeutic resistance to platinum-based drugs by targeting Epithelial-Mesenchymal transition.
Electronic publication date November 1, 2022
Xirui Duan [...] Ke Xie et al.
Platinum-based drugs (PBDs), including cisplatin, carboplatin, and oxaliplatin, have been widely used in clinical practice as mainstay treatments for various...
Conflict of interest statement
MeSH
- •
- •
- •
- •
- •
- •
- •
Specialties
- •
- •
- •
- •
- •
Substances
- •
- •
- •
- •
- •
- •
- •
- •
- •